UBS O'Connor’s Iterum Therapeutics ITRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-5,867
| Closed | -$124K | – | 865 |
|
|
2021
Q1 | $124K | Hold |
5,867
| – | – | ﹤0.01% | 716 |
|
|
2020
Q4 | $87K | Hold |
5,867
| – | – | ﹤0.01% | 406 |
|
|
2020
Q3 | $92K | Hold |
5,867
| – | – | ﹤0.01% | 228 |
|
|
2020
Q2 | $105K | Sell |
5,867
-46
| -0.8% | -$823 | ﹤0.01% | 291 |
|
|
2020
Q1 | $240K | Hold |
5,913
| – | – | ﹤0.01% | 250 |
|
|
2019
Q4 | $399K | Hold |
5,913
| – | – | 0.01% | 239 |
|
|
2019
Q3 | $523K | Hold |
5,913
| – | – | 0.01% | 223 |
|
|
2019
Q2 | $610K | Buy |
+5,913
| New | +$610K | 0.01% | 179 |
|
|
2019
Q1 | – | Sell |
-6,601
| Closed | -$496K | – | 81 |
|
|
2018
Q4 | $496K | Sell |
6,601
-66
| -1% | -$4.96K | 0.02% | 185 |
|
|
2018
Q3 | $670K | Hold |
6,667
| – | – | 0.02% | 218 |
|
|
2018
Q2 | $1.09M | Buy |
+6,667
| New | +$1.09M | 0.02% | 201 |
|